Member Info for sharehead

At 1p if the funding was sorted the expectations were this would go to 3 to 5p range and then rise further as the company revenues, product lines etc grow. So at 0.25p with finances sorted 0.5p is equipment to 2p so most will expect 1p to 2p as an early target with much higher for those who believe in the company rather than a trading opportunity- so I think traders will want over 1p to start selling and institutional buyers and LTHs have eyes set on much higher targets - imo

We’re trading well above 0.25p because it was waiting for funding news to rise significantly - it’s been in mid 30ps before Woodford was a forced seller - maybe 40p plus target is now 10p plus target because of dilution but still lot of potential here for rises I hope

More collaborations, expanded production, increased sales and revenues, Director BUYs...

Yes SP has took an unfortunate hammering but now fully Funded with route upwards imo

More shares but bags of cash in the bank and runway of news and collaborations hopefully- the funding held the sp back so maybe now we can fly !

Fully funded and fast growing business with new collaborations expected - a lot of new shares could be sticky ?

So if directors can’t BUY because they are in a closed period- but have told us they will BUY once results are released- then presumably the results and news flow is good and they are expecting the placing levels to be very profitable- for the rest of us - at least if news flow now positive with no financial concerns it means we have a route upwards

What makes this so exciting is yesterday’s RNS raises the prospect of new on finance deal to imminent and on top of that growth news on products and new pharma tie ups - what else is offering such a mouth watering mix of opportunities right now - as well as excellent medium to long term growth?

I see 2p as the next test- however as you’ve all stated below it’s the 6p to 10p range that should be achievable that people are more focused on

Great RNS today - there has never been any issues here with the products and huge potential- sp down at these levels due to run of bad luck that was not of TRX making- but now that means the upside from here is breathtaking imo

Yeah I expect multiples of current sp soon - just started re-rate imo

As pleased as I am that another big pharmaceutical have picked us (following due diligence) and sp is rightfully re-rating - I’m here for 40p plus - even if that takes a few years- not be selling for 10p in the short term that’s for sure !!

Game Changer - exactly- big pharma rolling out new products with us - sounds like a company whose plans are all coming together

Risk / Reward - risk is they need funds - however fast expansion will provide confidence to lenders to extend loan facilities. Reward - sp is only 1p for a company at the forefront of industry worth billions - sp has been significantly higher and could multi bag numerous times over

They have been given loan facilities to date - I think they will get extensions to these - but let’s see

Can see funds buying in big here. It’s been in 30p to 40p range before and can see no reason it can’t (eventually) get back there

This was comfortable above 30p before Neil Woodford, who was a massive believer, unfortunately became a forced seller. TRX have to build the sp all over again now - but from these levels what an amazing opportunity I think

Today’s RNS says new collaboration will increase revenues without impacting other product lines due to the expansion of facilities. TRX will have had to share how they will finance the company to close these agreements- whether that be self financing through increased revenues or an extended loan facility. The fact is they are accelerating growth and the sp is not even close to reflecting any of this yet imo.

The fact they are getting new collaborations shows great confidence

Most exciting company on AIM

Exciting news